Clinical trial
Intranasal Steroids and the Nasal Ocular Response
NCT00473915 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00473915 |
|---|---|
| Title | Intranasal Steroids and the Nasal Ocular Response |
| Official title | Intranasal Steroids Prevent Antigen-Induced Hyperresponsiveness of the Nasal Ocular Response |
| Lead sponsor | University of Chicago, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Seasonal Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | fluticasone furoate |
| Enrollment | 20 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | May 16, 2007 |
| Last update posted | Jun 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: